Closed-loop control apparatus example

Lecture Notes in Control and Information Sciences

Volumn 368, Issue , 2007, Pages 109-126

  Chee, Frederick ^a   Fernando, Tyrone ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35548961500     PISSN: 01708643     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-74031-5_5     Document Type: Article

References (252)

1. J. Desemore, J.P. Mordes, and A.A. Rossini. Hypoglycemia. In J.M. Rippe, R.S. Irwin, J.S. Alpert, and M.P. Fink, editors, Intensive Care Medicine 2nd Ed., chapter 99, pages 1000-1009. Little, Brown and Company, 1991.
2. I.B. Hirsch and J.B. McGill. Role of insulin in management of surgical patients with diabetes melliltus. Diabetes Care, 13(9):980-991, September 1990.
3. W.F. Ganong. Review of Medical Physiology. Appleton & Lange, Stanford, Connecticut, 1997.
4. A.C. Guyton and J.E. Hall. Textbook of Medical Physiology. W.B. Saunders Company, 9 edition, 1996.
5. I.A. Macfarlane. The Millenia Before Insulin, volume 1, chapter 1, pages 3-9. Blackwell Scientific Publications, 1991.
6. M. Bliss. The Discovery of Insulin, volume 1, chapter 2, pages 10 14. Blackwell Scientific Publications, 1991.
7. B.A. Mizock. Alterations in carbohydrate metabolism during stress: A review of the literature. The American Journal of Medicine, 98:75-84, January 1995.
8. N.B. Watts, S.S.P. Gebhart, R.V. Clark, and L.S. Phillips. Postoperative management of diabetes mellitus: Steady-state glucose control with bedside algorithm for insulin adjustment. Diabetes Care, 10(6):722-728, Nov - Dec 1987.
9. G. Van den Berghe, P. Wouters, F. Weekers, C. Verwaest, F. Bruyninckx, M. Schetz, D. Vlasselaers, P. Ferdinande, P. Lauwers, and R. Bouillon. Intensive insulin therapy in critically ill patients. N Engl J Med, 345(19):1359-1367, 2001.
10. A.M. Albisser and B.S. Leibel. Artificial beta cell, 1981. US Patent 4,245,643.
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 329(14):977-986, 30 September 1993.
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352:837-853, 12 September 1998.
13. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, S. Motoyoshi, Y. Kojima, N. Furuyoshi, and M. Shichiri. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomised prospective 6-year study. Diabetes Research and Clinical practice, 28:103-117, May 1995.
14. S.H. Golden, C. Peart-Vigilance, W.H. L. Kao, and F.L. Brancati. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care, 22(9):1408-1414, September 1999.
15. L.C. Gatewood, E. Ackerman, J.W. Rosevear, and G.D. Moinar. Simulation studies of blood-glucose regulation: Effect of intestinal glucose absorption. Computers and Biomedical Research, 2:15-27, 1968.
16. A.H. Clemens, P.H. Chang, and R.W. Myers. The development of Biostator, a glucose-controlled insulin infusion systems (GCIIS). Harm Metab Res Suppl, 7:23 33, March 1977.
17. A.M. Albisser, B.S. Leibel, T.G. Ewart, Z. Davidovac, C.K. Botz, and W. Zingg. Clinical control of diabetes by the artificial pancreas. Diabetes, 23(5):397-404, May 1974.
18. D.J. Chisolm, E.W. Kraegen, D.J. Bell, and D.R. Chipps. A semi-closed loop computer-assisted insulin infusion system: Hospital use for control of diabetes in patients. Med J Aust, 141:784-788, 1984.
19. L. Heinemann and F. J. Ampudia-Blasco. Glucose clamps with the Biostator: A critical reappraisal. Horm Metab Res, 26:579-583, 1994.
20. U. Fischer, K. Rebrin, T.v. Woedtke, and P. Abel. Clinical usefulness of the glucose concentration in the subcutaneous tissue - properties and pitfalls of electrochemical biosensors. Horm. Metab Res, 26:515-522, 1994.
21. U. Fischer. Continuous in vivo monitoring in diabetes: the subcutaneous glucose concentration. Acta Anaesthesiol Sound Suppl, 39(104):21-29, 1995.
22. E. F. Pfeiffer. Review, on the way to the automated (blood) glucose regulation in diabetes: the dark past, the gray present and the rosy future. Diabetologia, 30:51-65, 1987.
23. A.M. Albisser. Insulin delivery systems: Do they need a glucose sensor? Diabetes Care, 5(3):166-173, May-June 1982.
24. B.H. Ginsberg. An overview of minimally invasive technologies. Clin. Chem., 38(9): 1596-1600, 1992.
25. K. Rebrin, G. M. Steil, William P. Van Antwerp, and John J. Mastrototaro. Subcutaneous glucose predicts plasma glucose independent of insulin: Implications for continuous monitoring. Am J Physiol Endocrinol. Metab. 40, 277:E561-E571, 1999.
26. C. Meyerhoff, E. Bischf, F. Sternberg, H. Zier, and E.F. Pfeiffer. On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia, 35:1087-1092, 1992.
27. A. Heller. Implanted electrochemical glucose sensor for the management of diabetes. Annu. Rev. Biomed. Eng., 1:153-175, 1999.
28. B.H. Ginsberg. The role of technology in diabetes therapy. Diabetes Care, 17 Suppl. 1:50-55, June 1994.
29. Editorial. Problems associated with subcutaneously implanted glucose sensors. Diabetes Care, 22(2):143-148, February 1999.
30. M. Shichiri, R. Kawamori, Y. Goriya, Y. Yamasaki, M. Nomura, N. Hakui, and H. Abe. Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas. Diabetologia, 24:179-184, 1983.
31. M. Shichiri, R. Kawamori, Y. Goriya, Y. Yamasaki, M. Nomura, N. Hakui, and H. Abe. Closed-loop glycaemic control with a wearable artificial endocrine pancreas - variations in daily insulin requirements to glycemic response. Diabetes, 33:1200-1202, December 1984.
32. Tran Minh Canh. Biosensors, volume 1 of Sensor Physics and Technology Series, chapter 2, pages 7 19. Chapman & Hall and Masson, 2-6 Boundary Row, London SE1 8HN, 1993.
33. Gbor Harsnyi. Sensors in Biomedical Applications, - Fundamentals, Technology & Applications. Technomic Publishing Company, Inc., Pennsylvania USA, 2000.
34. MiniMed. MiniMed glucose sensor - instructions for use (REF MMT-7002). Northridge, CA, May 2001.
35. V. Poitout, D. Moatti-Sirat, G. Reach, Y. Zhang, G.S. Wilson, F. Lemonnier, and J. C. Klein. A glucose monitoring system for on-line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit. Diabetologia, 36:658-663, 1993.
36. J.S. Schultz, S. Mansouri, and I.J. Goldstein. Affinity sensor: A. new technique for developing implantable sensors for glucose and other metabolites. Diabetes Care, 5(3):245-253, 1982.
37. J.I. Peterson and G.G. Vurek. Fiber-optic sensors for biomedical applications. Science, 224(4645): 123-127, 1984.
38. R.J. McNichols and G.L. Coté. Optical glucose sensing in biological fluids: an overview. Journal of Biomedical Optics, 5(1):5-16, January 2000.
39. L.J. McCartney, J.C. Pickup, O.J. Rolinski, and D.J.S. Birch. Near-infrared fluorescence lifetime assay for serum glucose based on Allophycocyanin-Labeled Concanavalin A. Analytical Biochemistry, 292:216-221, 2001.
40. J.C. Pickup, F. Hussain, N.D. Evans, O.J. Rolinski, and D.J.S. Birch. Fluorescence-based glucose sensors. Biosensors and Bioelectronics, 20:2555-2565, 2005.
41. J. Pickup, L. McCartney, O. Rolinski, and D. Birch. In vivo glucose sensing for diabetes management: Progress towards non-invasive monitoring. BMJ, 319:1 4, 13 November 1999.
42. R. Ballerstadt and J.S. Schultz. A fluorescence affinity hollow fiber sensor for continuous transdermal glucose monitoring. Analytical Chemistry, 72:4185-4192, 2000.
43. J.S. Kristensen, S. Aasmul, J.K. Nielsen, and J.S. Christiansen. Transcutaneous fluorescence lifetime based continuous glucose reading for long term interrogation, 2005. Poster at 65th annual American Diabetes Association meeting 2005, Download from http://www.precisense.com/graphics/Synkron-Library/ Products/ presicense_handout_higress.pdf.
44. W.F. March, K. Ochsner, and J. Horna. Intraocular lens glucose sensor. Diabetes Technology & Therapeutics, 2(1):27-30, 2000.
45. L. Li and D.R. Walt. Dual-analyte fiber-optic sensor for the simultaneous and continuous measurement of glucose and oxygen. Analytical Chemistry, 67:3746-3752, 1995.
46. H. Gunasingham, Chin-Huat Tan, and J.K.L. Seow. Fiber-optic glucose sensor with electrochemical generation of indicator reagent. Analytical Chemistry, 62:755-759, 1990.
47. M.S. Abdel-Latif and G.G. Guilbault. Fiber-optic sensor for the determination of glucose using micellar enhanced chemiluminescence of the peroxyoxalate reaction. Analytical Chemistry, 60:2671-2674, 1988.
48. N. Wisniewski, F. Moussy, and W.M. Reichert. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem, 366:611-621, 2000.
49. M.J. McShane. Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes Technology & Therapeutics, 4(4):533 538, 2002.
50. E.F. Pfeiffer. The "Ulm Zucker Uhr System" and its consequences. Horm Metab Res, 26:510 514, 1994.
51. J.A. Tamada, M. Lesho, and M.J. Tierney. Keeping watch on glucose - New monitors help fight the long-term complications of diabetes. IEEE Spectrum, 39(4):52-57, 2002.
52. S. Mansouri and J.S. Schultz. A miniature optical glucose sensor based on affinity binding. Biotechnology, 2:885-890, October 1984.
53. J.C. Pickup. In vivo glucose monitoring: Sense and sensorbility. Diabetes Care, 16(2):535-539, 1993.
54. D.C. Klonoff. Noninvasive blood glucose monitoring. Diabetes Care, 20(3):433-437, March 1997.
55. J.A. Tamada, S. Garg, L. Jovanovic, K.R. Pitzer, S. Fermi, R.O. Potts, and the Cygnus Research Team. Noninvasive glucose monitoring - Comprehensive clinical results. JAMA, 282(19):1839-1844, November 1999.
56. M.J. Tierney, Y. Jayalakshmi, N.A. Parris, M.P. Reidy, C. Uhegbu, and P. Vijayakumar. Design of a biosensor for continual, transdermal glucose monitoring. Clinical Chemistry, 45(9):1681-1683, 1999.
57. S.K. Garg, R.O. Potts, N.R. Ackerman, S.J. Fermi, J.A. Tamada, and H.P Chase. Correlation of Fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care, 22(10):1708-1712, October 1999.
58. J. Kost. Ultrasound-assisted insulin delivery and noninvasive glucose sensing. Diabetes Technology & Therapeutics, 4(4):489-497, 2002.
59. S. Mitragotri, M. Coleman, J. Kost, and R. Langer. Transdermal extraction of analytes using low-frequency ultrasound. Pharmaceutical Research, 17(4):466-470, 2000.
60. J. Kost, S. Mitragotri, R.A. Gabbay, M. Pishko, and R. Langer. Transdermal monitoring of glucose and other analytes using ultrasound. Nature Medicine, 6(3):347-350, March 2000.
61. S. Gebhart, M. Faupel, R. Fowler, C.Kapsner, D. Lincoln, V. McGee, J. Pasqua, L. Steed, M. Wangsness, F. Xu, and M. Vanstory. Glucose sensing in transdermal body fluid collected under continuous vacuum pressure via micropores in the stratum corneum. Diabetes Technology & Therapeutics, 5(2):159 166, 2003.
62. J.A. Eppstein, M.R. Hatch, and D. Yang. Microporation of human skin for drug delivery and monitoring applications, 2000. United States Patent US 6,142,939.
63. L. Heinemann and G. Schmelzeisen-Redeker on behalf of the Non-invasive task force NITF. Non-invasive continuous glucose monitoring in type I diabetic patients with optical glucose sensors. Diabetologia, 41:848-854, 1998.
64. J.W. Hall and A. Pollard. Near-infrared spectrophotometry: A new dimension in clinical chemistry. Clinical Chemistry, 38(9): 1623-1631, 1992.
65. John A Dean. Dean's Analytical Chemistry Handbook. McGraw-Hill, New York, 2nd edition, 2004.
66. Y. Mendelson, A.C. Clermont, R.A. Peura, and Been-Chyuan Lin. Blood glucose measurement by multiple attenuated total reflection and infrared absorption spectroscopy. IEEE Trans. Biomed. Eng., 37(5):458-465, May 1990.
67. D.A. Skoog and J.J. Leary. Principles of Instrumental Analysis. Saunders College Publishing, Florida, USA, 4th edition, 1992.
68. K. Danzer, Ch. Fischbacher, K.U. Jagemann, and K.J. Reicheit. Near-infrared diffuse reflection spectroscopy for non-invasive blood glucose monitoring. IEEE-LEOS Newsletter (Special issue), pages 9 11, April 1998.
69. Yoen-Joo Kim and G. Yoon. Prediction of glucose in whole blood by near-infrared spectroscopy: Influence of wavelength region, preprocessing, and hemoglobin concentration. Journal of Biomedical Optics, 11(4):041128, July/August 2006.
70. J.J. Burmeister and M.A. Arnold. Spectroscopic considerations for noninvasive blood glucose measurements with near infrared spectroscopy. IEEE-LEOS Newsletter (Special issue), pages 6-9, April 1998.
71. G. Yoon, A.K. Amerov, K.J. Jeon, J.B. Kim, and Y-J Kim. Optical measurement of glucose levels in scattering media, volume 20, pages 1897-1899. IEEE, 1998.
72. R. Abbink and C. Gardner. Getting under the skin, spie's oemagazine, pages 18-20, September 2003.
73. N. Kaiser. Laser absorption spectroscopy with an ATR prism - noninvasive in vivo determination of glucose. Horm Metab Res Suppl, 8:30-33, 1979.
74. P. Zheng, C.E. Kramer, C.W. Barnes, J.R. Braig, and B.B. Sterling. Noninvasive glucose determination by oscillating thermal gradient spectrometry. Diabetes Technology & Therapeutics, 2(1):17-26, 2000.
75. G.B. Christison and H.A. MacKenzie. Laser photoacoustic determination of physiological glucose concentrations in human whole blood. Medical & Biological Engineering & Computing, 31(3):284-290, 1993.
76. H.A. MacKenzie, H.S. Ashton, S. Spiers, Y. Shen, S.S Freeborn, J. Hannigan, J. Lindberg, and P. Rae. Advances in photoacoustic noninvasive glucose testing. Clinical Chemistry, 45(9):1587 1595, 1999.
77. F.M. Ham, G.M. Cohen, K. Patel, and B.R. Gooch. Multivariate determination of glucose using NIR spectra of human blood serum. In Proceedings of the 16th Annual International Conference of the IEEE on Engineering Advances: New Opportunities for Biomedical Engineers, volume 2, pages 818-819, Baltimore, MD, USA, 03 November-06 November 1994. IEEE, IEEE Engineering in Medicine and Biology Society, 1994.
78. Ch. Fischbacher, K.-U. Jagemann, K. Danzer, U.A. Müller, L. Papenkordt, and J. Schüler. Enhancing calibration models for non-invasive near-infrared spectroscopicsl blood glucose determination. .Fresenius J Anal Chem, 359:78-82, 1997.
79. M.R. Robinson, R.P. Eaton, D.M. Haaland, G.W. Koepp, and E.V. Thomas. Noninvasive glucose monitoring in diabetic patients: A preliminary evaluation. Clinical Chemistry, 38(9):1618-1622, 1992.
80. G.W. Small, M.A. Arnold, and L.A. Marquardt. Strategies for coupling digital filtering with partial least-squares regression: Application to the determination of glucose in plasma by Fourier Transform Near Infrared spectroscopy. Analytical Chemistry, 65:3279-3289, 1993.
81. H.M. Heise and R. Marbach. Multivariate determination of glucose in whole blood by attenuated total reflection infrared spectroscopy. Analytical Chemistry, 61:2009-2015, 1989.
82. J. Tenhunen, H. Kopola, and R. Myllylä. Non-invasive glucose measurement based on selective near infrared absorption requirements on instrumentation and spectral range. Measurement, 24:173-177, 1998.
83. PerkinElmer Inc. FT-IR spectroscopy: Attenuated total reflectance (ATR) - Technical Note, 2007. [Online] Available at http://las.perkineImer.com/content/ TechnicalInfo/TCH.FTIRATR.pdf.
84. H.M. Heise. Non-invasive monitoring of metabolites using near infrared spectroscopy: State of the art. HormMetabRes, 28:527-534, 1996.
85. G.M. Oosta, Tayy-Wen Jeng, J.M. Lindberg, M.L. McGlashen, and J.L. Pezzaniti. Multiplex sensor and method of use, 2003. United States Patent US 6,567,678 B1.
86. C.D. Malchoff, K. Shoukri, J.I. Landau, and J.M. Buchert. A novel noninvasive blood glucose monitor. Diabetes Care, 25(12):2268 2275, December 2002.
87. D.C. Klonoff and J. Braig. Mid-infrared spectroscopy for noninvasive blood glucose monitoring. IEEE-LEOS Newsletter (Special issue), pages 13-14, April 1998.
88. J.R. Braig, C.E. Kramer, B.B. Sterling, D.S. Goldberger, P.Zheng, A.M. Shulenberger, R. Trebino, R.A. King, and C.W. Barnes. Method for determining analyte concentration using periodic temperature modulation and phase detection, 2006. United States Patent US 7,006,857 B2.
89. L. Heinemann, U. Krämer, Hans-Martin Klötzer, M. Hein, D. Volz, M. Hermann, T. Heise, and K. Rave the Non-invasive task force NITF. Non-invasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Diabetes Technology & Therapeutics, 2(2):211 220, 2000.
90. S.L. Jacques and S.A. Prahl. ECE532 Biomedical Optics, Oregon Graduate Institute, 1998. [Online] Available at http://www.phas.ubc.ca/~mackay/phys404/ documents/BiomedicalOptics/ece532/class3/mie.html.
91. J.T. Bruulsema, J.E. Hay ward, T.J. Farrell, and M.S. Patterson. Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient. Optics Letters, 22(3):190-192, February 1997.
92. M. Kohl, M. Essenpreis, and M. Cope. The influence of glucose concentration upon the transport of light in tissue-simulating phantoms. Phy. Med. Biol, 40:1267-1287, 1995.
93. J.S. Maier, S.A. Walker, S. Fantini, M.A. Franceschini, and E. Gratton. Possible correlation between blood glucose concentration and the reduced scattering coefficient of tissues in the near infrared. Optics Letters, 19(24):2062-2064, December 1994.
94. O.S. Khalil. Spectroscopic and clinical aspects of noninvasive glucose measurements. Clin. Chem., 45(2):165-177, 1999.
95. M. Kinnunen, R. Myllylä, T. Jokela, and S. Vainio. In vitro studies toward noninvasive glucose monitoring with optical coherence tomography. Applied Optics, 45(10):2251-2260, 1 April 2006.
96. H.M. Heise. Diffuse reflectance near-infrared spectrometry for non-invasive blood glucose monitoring. IEEE-LEOS Newsletter (Special issue), pages 11-13, April 1998.
97. A. Kienle, L. Lilge, M.S. Patterson, R. Hibst, and R. Steiner. Spatially resolved absolute diffuse reflectance measurements for noninvasive determination of the optical scattering and absorption coefficients of biological tissue. Applied Optics, 35(13):2304-2314, 1 May 1996.
98. K.V. Larin, M.S. Eledrisi, M. Motamedi, and R.O. Esenaliev. Noninvasive blood glucose monitoring with optical coherence tomography. Diabetes Care, 25(12):2263-2267, December 2002.
99. E.M.C. Hillman. Optical Tomography, volume 4, pages 2203 2235. Wiley-VCH Verlag GmBH & Co. KGaA, 2003.
100. D. Huang, E.A. Swanson, C.P. Lin, J.S. Schuman, W.G. Stinson, W. Chang, M.R. Hee, T. Flotte, K. Gregory, C.A. Puliafito, and J.G. Fujimoto. Optical coherence tomography. Science, 254(5035):1178-1181, 22 November 1991.
101. Ilya Fine. Non-invasive method and system of optical measurements for determining the concentration of a substance in blood, 2002. United States Patent US 6,400,972 B1.
102. I. Fine, B. Fikhte, and L.D. Shvartsman. Occlusion spectroscopy as a new paradigm for non-invasive blood measurements. Proceedings of SPIE, 4263:122-130, 2001.
103. O. Cohen, I. Fine, E. Monashkin, and A. Karasik. Glucose correlation with light scattering patterns - novel method for non-invasive glucose measurements. Diabetes Technology & Therapeutics, 5(1):11-17, 2003.
104. L.D. Shvartsman and I. Fine. Light scattering changes caused by RBC aggregation: Physical basis for new approach to non-invasive blood count. Proceedings of SPIE, 4263:131-142, 2001.
105. K. Yamakoshi and Y. Yamakoshi. Pulse glucometry: a new approach for noninvasive blood glucose measurement using instantaneous differential nearinfrared spectrophotometry. Journal of Biomedical Optics, 11(5):054028, September/October 2006.
106. (NJ, USA) Princeton Instruments Inc and (MA, USA.) Acton Research Corp. Raman spectroscopy basics, 2006. [Online] Available at http://architect.wwwcomm. com/Uploads/Princeton/Documents/Library/App_Wht_Papers/Raman_B asics.pdf.
107. USA Kaiser Optical Systems Inc, MI. Raman Technical Resources - Raman Tutorial, 2006. [Online] Available at http://www.kosi.com/raman/resources/ tutorial/index.html.
108. Tae-Wong Koo, A.J. Berger, I. Itzkan, G. Horowitz, and M.S. Feld. Measurement of glucose in human blood serum using Raman spectroscopy. IEEE-LEOS Newsletter (Special issue), pages 18 19, April 1998.
109. R.J. McNichols, B.D. Cameron, and G.L. Coté. Development of a non-invasive Polarimetric glucose sensor. IEEE-LEOS Newsletter (Special issue), pages 30 31, April 1998.
110. J. Lambert, M. Storrie-Lombardi, and M. Borchert. Measurement of physiologic glucose levels using Raman spectroscopy in a rabbit aqueous humor model. IEEE-LEOS Newsletter (Special issue), pages 19-22, April 1998.
111. A.J. Berger, Tae-Woong Koo, I. Itzkan, G. Horowitz, and M.S. Feld. Multicomponent blood analysis by near-infrared Raman spectroscopy. Applied Optics, 38(13):2916-2926, 1 May 1999.
112. L.D. Barron. Molecular Light Scattering and Optical Activity. Cambridge University Press, Cambridge CB2 1RP, 1982.
113. Giordan G. Hammes. Spectroscopy for the biological sciences. John Wiley & Sons Inc, New Jersey, USA, 1sh edition, 2005.
114. B.D. Cameron and G.L. Coté. Noninvasive glucose sensing utilizing a digital closed-loop Polarimetric approach. IEEE Trans. Biomed. Eng., 44(12):1221-1227, December 1997.
115. G.L. Cote, M.D. Fox, and R.B. Northrop. Optical Polarimetric sensor for blood glucose measurement. Proceedings of the 1990 Sixteenth Annual Northeast Bioengineering Conference, 1990, pages 101 102, 26-27 March 1990.
116. G.L. Cote, M.D. Fox, and R.B. Northrop. Laser Polarimetric sensor for glucose monitoring. Proceedings of the Twelfth Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pages 476-477, 1-4 November 1990.
117. H. Anumula, A. Nezhuvingal, Y. Li, and B.D. Cameron. Development of a noninvasive corneal birefringence compensated glucose sensing Polarimeter. SPIE-The International Society for Optical Engineering, 4958:303-312, February 2003.
118. G.L. Cote, M.D. Fox, and R.B. Northrop. Noninvasive optical Polarimetric glucose sensing using a true phase measurement technique. IEEE Trans. Biomed. Eng., 39(7):752 756, July 1992.
119. G.L. Cote, M.D. Fox, and R.B. Northrop. Optical glucose sensing apparatus and method, 1993. United States Patent US 5,209,231.
120. A.F. Browne, T.R. Nelson, and R.B. Northrop. Microdegree Polarimetric measurement of glucose concentrations for biotechnology applications. Proceedings of the IEEE 1997 23rd Northeast Bioengineering Conference, 1997, pages 9-10, 21-22 May 1997.
121. C. Chou, Chien-Yuan Han, Wen-Chuan Kuo, Yen-Chuen Huang, Ching-Mei Feng, and Jenn-Chyang Shyu. Noninvasive glucose monitoring in vivo with an optical heterodyne Polarimeter. Applied Optics, 37(16):3553-3557, 1998.
122. C. Chou and Po-Kang Lin. Noninvasive glucose monitoring with optical heterodyne technique. Diabetes Technology & Therapeutics, 2(1):45 47, 2000.
123. S. Jang and M.D. Fox. Optical sensor using the magnetic optical rotatory effect of glucose. IEEE-LEOS Newsletter (Special issue), pages 28-30, April 1998.
124. R.W. Waynant and V.M. Chenault. Overview of non-invasive fluid glucose measurement using optical techniques to maintain glucose control in diabetes mellitus. IEEE-LEOS Newsletter (Special issue), pages 3-6, April 1998.
125. Andrew C. Tam. Applications of photoacoustic sensing techniques. Reviews of Modern Physics, 58(2):381-431, April 1986.
126. R. Nagar, B. Pesach, and U. Ben-Ami. Photoacoustic assay and imaging system, 2005. United States Patent US 6,846,288 B2.
127. C. Ruff, S. Lohmann, H. Lubatschowski, and W. Ertner. Photoacoustic determination of optical parameters of biological tissue, pages 325-325. IEEE, 8-13 September 1996.
128. Zuomin Zhao. Pulsed photoacoustic techniques and glucose determination in human blood and tissue. ISBN 951-42-6689-7. Oulu University Press, Oulu, 2002. [Online] Available from http://herkules.oulu.fi/isbn9514266900/.
129. Z. Zhao and R.A. Myllylä. Photoacoustic blood glucose and tissue measurements based on optical scattering effect. Proceedings of the SPIE, 4707:153 157, July 2002.
130. K.M. Quan, E.M. Johnston, and H.A. MacKenzie. Noninvasive glucose monitoring using nearinfrared photoacoustic spectroscopy, pages 264-264. IEEE, 28 August-2 September 1994.
131. G. Spanner and R. Nießner. Noninvasive determination of blood constituents using an array of modulated laser diodes and a photoacoustic sensor head. Fresenius J Anal Chem, 355:327 328, 1996.
132. G. Spanner and R. Nießner. New concept for the non-invasive determination of physiological glucose concentrations using modulated laser diodes. Fresenius J Anal Chem, 354:306-310, 1996.
133. R. Weiss, Y. Yegorchikov, A. Shusterman, and I. Raz. Noninvasive continuous glucose monitoring using photoacoustic technology - Results from the first 62 subjects. Diabetes Technology & Therapeutics, 9(1):68-74, 2007.
134. S.A. Asher and J.H. Holtz. Glucose sensing intelligent polymerized crystalline colloidal arrays. IEEE-LEOS Newsletter (Special issue), pages 32-34, April 1998.
135. A.J. Marshall, D.S. Young, J. Blyth, S. Kabilan, and C.R. Lowe. Metabolitesensitive holographic biosensors. Analytical Chemistry, 76:1518 1523, 2004.
136. S. Kabilan, A.J. Marshall an F.K. Sartain, M. Lee, A. Hussain, X. Yang, J. Blyth, N. Karangu, K. James, J. Zeng, D. Smith, A. Domschke, and C.R. Lowe. Holographic glucose sensors. Biosensors and Bioelectronics, 20:1602-1610, 2005.
137. A. Domschke, W.F. March, S. Kabilan, and C. Lowe. Initial clinical testing of a holographic non-invasive contact lens glucose sensor. Diabetes Technology & Therapeutics, 8(1):89-93, 2006.
138. Y. Hayashi, L. Livshits, A. Caduff, and Y. Feldman. Dielectric spectroscopy study of specific glucose influence on human erythrocyte membranes. Journal of Physics D: Applied Physics, 36:369-374, 2003.
139. A. Sieg, R.H. Guy, and M.B. Delgado-Charro. Noninvasive and minimally invasive methods for transdermal glucose monitoring. Diabetes Technology & Therapeutics, 7(1):174-197, 2005.
140. A. Caduff, E. Hirt, Y. Feldman, Z. Ali, and L. Heinemann. First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosensors and Bioelectronics, 19:209-217, 2003.
141. G. Velho, PH. Froguel, D.R.Thevenot, and G. Reach. Strategies for calibrating a subcutaneous glucose sensor. Biomed. Biochim, Acta, 48(11/12):957-964, 1989.
142. U. Fischer, R. Ertle, K. Rebrin, E. Brunstein, H. Hahn von Dorsche, and E.J. Freyse. Assessment of subcutaneous glucose concentration: Validation of the wick in normal technique as a reference for implanted electrochemical sensors in normal and diabetic dogs. Diabetologia, 30:940-945, 1987.
143. MiniMed Inc., Sylmar CA. MiniMed CGMStm continuous glucose monitoring system User's Guide, March 2000.
144. M.J. Tierney, J.A. Tamada, R.O. Potts, L. Jovanovic, S. Gard, and Cygnus Research Team. Clinical evaluation of the glucowatch(r) biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosensors & Bioelectronics, 16:621-629, 1999.
145. John Pickup. Sensitive glucose sensing in diabetes. The Lancet, 355:426-427, 5 February 2000.
146. B. Berner, T.C. Dunn, K.C. Farinas, M.D. Garrison, R.T. Kurnik, M.J. Lesho, R.O. Potts, J.A. Tamada, and M.J. Tierney. Signal processing for measurement of physiological analysis, 2001. United States Patent US 6,233,471 B1.
147. R.T. Kurnik, J.J. Oliver, S.R. Waterhouse, T. Dunn, Y. Jayalakshmi, M. Lesho, M. Lopatin, J. Tamada, C. Wei, and R.O. Potts. Application of the mixtures of experts algorithm for signal processing in a noninvasive glucose monitoring system. Sensors and Actuators B, 60:19-26, May 1999.
148. G.M. Steil, K. Rebrin, P.V. Goode, J.J. Mastrototaro, R.E. Purvis, W.P. van Antwerp, and J.J. Shin. Closed loop system for controlling insulin infusion, 2000. World Intellectual Property Organization WO00/74753 A1.
149. William L. Clarke, Daniel Cox, Linda A. Gonder-Frederick, William Carter, and Stephen L. Pohl. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care, 10(5):622-628, 1987.
150. P.D. Home. Alternative Methods, Systems and Routes of Insulin Delivery, volume 1, chapter 46, page 446. Blackwell Scientific Publications, 1991.
151. L.L. Young and M.A. Koda-Kimble. Applied Therapeutics: The clinical use of drugs., chapter 48. Applied Therapeutics, Inc., Vancouver WA, 7th edition, 2000.
152. N. Pørksen. The in vivo regulation of pulsatile insulin secretion. Diabetologia, 45:3-20, 2002.
153. W.C. Duckworth, C.D. Saudek, and R.R. Henry. Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes, 41:657-661, June 1992.
154. M.A. Fishel, G.S. Watson, T.J. Montine, Q. Wang, P.S. Green, J.J. Kulstad, D.G.Cook, E.R. Peskind, L.D. Baker, D.Goldgaber, W.Nie, S. Asthana, S.R. Plymate, M.W. Schwartz, and S. Craft. Hyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adults. Archives of Neurology, 62:1539 1544, 2005.
155. J.A. Luchsinger, Ming-Xin Tang, S. Shea, and R. Mayeux. Hyperinsulinemia and risk of alzheimer disease. Neurology, 63:1187-1192, 2004.
156. I.A. Macfarlane. The Pharmacokinetics of Insulin, chapter 38, pages 371-383. Blackwell Scientific Publications, 1991.
157. K.S. Polonsky, M.M. Byrne, and J. Sturis. Alternative insulin delivery systems: How demanding should the patient be? Diabetologia, 40:S97-S101, 1997.
158. J.P. Mordes and A.A. Rossini. Management of diabetes in the critically ill patient. In J.M. Rippe, R.S. Irwin, J.S. Alpert, and M.P. Fink, editors, Intensive Care Medicine 2nd Ed., chapter 92, pages 955-962. Little, Brown and Company, 1991.
159. N.M. O'Meara and K.S. Polonsky. Insulin secretion in vivo. In C.R. Kahn and G.C. Weir, editors, Joslin's Diabetes Mellitus 13th Ed, chapter 5, pages 81 96. Lea & Febiger, Malvern, Pennsylvania, 1994.
160. D. Elahi. In praise of the hyperglycemic clamp. Diabetes Care, 19(3):278-286, 1996.
161. L.C. Ramirez and P. Raskin. Pancreatic Abnormalities in Non-Insulin-Dependent Diabetes Mellitus, volume 1, chapter 22, pages 198-204. Blackwell Scientific Publications, 1991.
162. D.S.Bell. Importance of postprandial glucose control. South Med. J., 94(8):804-809, 2001.
163. E.W. Kraegen, D.J. Chisholm, and M.E. McNamara. Timing of insulin delivery with meals. Horm Metab Res, 13:365-367, 1981.
164. A. Motluk and L.Geddes. Breakthrough sheds light on cause of diabetes, 15 December 2006. New Scientist Tech [Online] Available at http://www. newscientisttech.com/article.ns?id=dn10812.
165. B.C. Borlase, T.J. Babineau, R.A. Forse, S.J. Bell, and G.L. Blackburn. Enteral nutritional support. In J.M. Rippe, R.S. Irwin, J.S. Alpert, and M.P. Fink, editors, Intensive Care Medicine 2nd Ed., chapter 174, pages 1669-1674. Little, Brown and Company, 1991.
166. D. Dazzi, F. Taddei, A. Gavarini, E. Uggeri, R. Negro, and A. Pezzarossa. The control of blood glucose in the critical diabetic patient: A neuro-fuzzy method. Journal of Diabetes and Complications, 15:80-87, 2001.
167. F. Chee, T. Fernando, and P.V. van Heerden. Closed-loop glucose control in critically-ill patients using continuous glucose monitoring system. (CGMS) in realtime. IEEE Trans. Inf. Tech. Biomed., 7(1):43-53, March 2003.
168. E. R. Carson, C. Cobelli, and L. Finkelstein. The Mathematical Modelling of Metabolic and Endocrine Systems - Model Formulation, Identification, and Validation, volume 2 of Biomedical Engineering and Health Systems. John-Wiley and Sons, 1983.
169. Y. Cherruault. Mathematical Modelling in Biomedicine. D. Reidel Publishing Company, Dordrecht, Holland, 1986.
170. J.C. Henquin. Cell biology of insulin secretion. In C. R. Kahn and G.C. Weir, editors, Joslin's Diabetes Mellitus 13th Ed, pages 56-80. Lea & Febiger, Malvern, Pennsylvania, 1994.
171. R.A. Rizza, L.J. Mandarino, and J.E. Gerich. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am. J. Physiol. (Endocrinol. Metab), 240:E630-E639, 1981.
172. A.M. Albisser, B.S. Leibel, T.G. Ewart, Z. Davidovac, C.K. Botz, and W. Zingg. An artificial endocrine pancreas. Diabetes, 23(5):389-396, May 1974.
173. E.W. Kraegen, R. Whiteside, D. Bell, Y.O. Chia, and L. Lazarus. Development of a closed-loop artificial pancreas. Horm Metab Res Suppl, 8:39-42, 1979.
174. J.D. Kruse-Jarres, G. Braun, R. Naegeie, M. Bresch, and U. Lehmann. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas. Horm Metab Res Suppl, 8:43-45, 1979.
175. N.H. White, D. Skor, and J.V. Santiago. Practical closed-loop insulin delivery: A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetes. Ann Intern Med, 97:210-213, 1982.
176. S.M. Furler, E.W. Kraegen, R.H. Smallwood, and D.J. Chisolm. Blood glucose control by intermittent loop closure in the basal mode: Computer simulation studies with a diabetic model. Diabetes Care, 8(6):553-561, 1985.
177. R.L. Ollerton. Application of optimal control theory to diabetes mellitus. Int. J. Control, 50(6):2503-2522, 1989.
178. P. Palazzo and V. Viti. A new glucose-clamp algorithm theoretical consideration and computer simulations. IEEE Trans. Biomed. Eng., 37(5):535-543, 1990.
179. F. Chee, T.L. Fernando, A.V. Savkin, and P.V. van Heerden. Expert PID control system for blood glucose control in critically-ill patients. IEEE Trans. Inf. Tech. Biomed., 7(4):419-425, December 2003.
180. G.M. Steil, A.E. Panteleon, and K. Rebrin. Closed-loop insulin delivery - the path to physiological glucose control. Advanced Drug Delivery Reviews, 56:125-144, 2004.
181. E. Renard, G. Costalat, H. Chevassus, and J. Bringer. Closed loop insulin
182. B. Gopakumaran, H.M. Duman, D.P. Overholser, I.F. Federiuk, M.J. Quinn, M.D. Wood, and W.K. Ward. A novel insulin delivery algorithm in rats with type 1 diabetes: The fading memory proportional-derivative method. Artifical Organs, 29(8):599-607, 2005.
183. G. Marchetti, M. Barolo, L. Jovanovic, and H. Zisser. An improved PID switching control strategy for Type 1 diabetes. In Proceedings of the 28th IEEE EMBS Annual International Conference, pages 5041-5044, New York City, USA, 30 August-3 September 2006. IEEE.
184. V.W. Bolie. Coefficients of normal blood glucose regulation. Journal of Applied Physiology, 16(5):783-788, 1961.
185. E. Ackerman, J.W. Rosevear, and W.F. McGuckin. A mathematical model of the glucose tolerance test. Physics in Medicine and Biology, 9(2):203-213, 1964.
186. E. Ackerman, Laël.C. Gatewood, J.W. Rosevear, and G.D. Molnar. Model studies of blood-glucose regulation. Bulletin of Mathematical Biophysics, 27:21-37, 1965. Special Issue.
187. L.C Gatewood, E. Ackerman, J. W. Rosevear, and G.D. Molnar. Test of a mathematical model of the blood-glucose regulatory system. Computers and Biomedical Research, 2:1-14, 1968.
188. F. Ceresa, F. Ghermi, P. F. Martini, P. Martino, G. Segre, and A. Vitelli. Control of blood glucose in normal and in diabetic subjects - studies by compartmental analysis and digital computer technics. Diabetes, 17(9):571-578, 1968.
189. T. Chorbajian. An in numero study of glucose-insulin interaction. Bulletin of Mathematical Biophysics, 33:451-462, 1971.
190. E. Cerasi, G. Fick, and M. Rudemo. A mathematical model for the glucose induced insulin release in man. European Journal of Clinical Investigation, 4:269-278, 1974.
191. M. Nomura, M. Shichiri, R. Kawamori, Y. Yamasaki, N. Iwama, and H. Abe. A mathematical insulin-secretion model and its validation in isolated rat pancreatic islets perifusion. Computers and Biomedical Research, 17:570-579, 1984.
192. J. S. Bajaj, G. Subba Rao, J. Subba Rao, and R. Khardori. A mathematical model for insulin kinetics and its application to protein-deficient (malnutrition-related) diabetes mellitus (PDDM). Journal of Theoretical Biology, 126:491-503, 1987.
193. G. Subba Rao, J. S. Bajaj, and J. Subba Rao. A mathematical model for insulin kinetics II. extension of the model to include response to oral glucose administration and application to insulin-dependent diabetes mellitus (IDDM). Journal of Theoretical Biology, 142:473-483, 1990.
194. L. Jansson, L. Lindskog, N. E. Norden, S. Carlstrom, and B. Schersten. Diagnostic value of the oral glucose tolerance test evaluated with a mathematical model. Computers and Biomedical Research, 13:512-521, 1980.
195. E. Salzsieder, G. Albrecht, U. Fischer, and E.-J Freyse. Kinetic modeling of glucoregulatory system to improve insulin therapy. IEEE Trans. Biomed. Eng., 32(10):846-855, October 1985.
196. R.N. Bergman and J. Urquhart. The pilot gland approach to the study of insulin secretory dynamics. Recent Prog Horm Res, 27:583-605, 1971.
197. R. N. Bergman, L. S. Phillips, and C. Cobelli. Physiological evaluation of factors controlling glucose tolerance in man, Journal of Clinical Investigation, 68:1456-1467, December 1981.
198. G. Toffolo, R. N. Bergman, D. T. Finegood, C. R. Bowden, and C Cobelli. Quantitative estimation of beta cell sensitivity to glucose in the intact organism - a minimal model of insulin kinetics in the dog. Diabetes, 29:979-990, December 1980.
199. B. Candas and J. Radziuk. An adaptive plasma glucose controller based on a nonlinear insulin/glucose model. IEEE Trans. Biomed. Eng., 41(2):116-124, February 1994.
200. F.J. Doyle III, C. Dorski, J. Halting, and N.A. Peppas. Control and modelling of drug delivery devices for the treatment of diabetes. In Proceedings of the American Conference, volume 1, pages 776-780, Seattle, Washington, USA, 21-23 June 1995. IEEE.
201. A. De Gaetano and O. Arino. Mathematical modeling of the intravenous glucose tolerance test. Journal of Mathematical Biology, 40:136-168, 2000.
202. C. Cobelli, G. Federspil, G. Pacini, A. Salvan, and C. Scandellari An integrated mathematical model of the dynamics of blood glucose and its hormonal control. Mathematical Biosciences, 58:27-60, 1982.
203. C. Cobelli and A. Mari. Control of diabetes with artificial systems for insulin delivery - algorithm independent limitations revealed by a modeling study. IEEE Trans. Biomed. Eng., 32(10):840-845, October 1985.
204. C. Cobelli, G. Pacini, G. Toffolo, and L. Sacca, Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. American Journal of Physiology, 250:E591-E598, 1986.
205. D. K. Parrish and D. B. Ridgely. Control of artificial human pancreas using the SDRE method. In Proceedings of the American Control Conference, pages 1059-1060, Albquerque, New Mexico, June 1997. Academic Press.
206. R. S. Parker, F. J. Doyle III, and N. A Peppas. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans. Biomed. Eng., 46(2):148-157, February 1999.
207. ∞ glucose control in diabetes using a physiological model. AIChE Journal, 46(12):2537-2549, December 2000.
208. E. Ruiz Velázquez, R, Femat, and D.U. CamposDelgado. Blood glucose control for type I diabetes mellitus: A robust H∞ tracking problem. Control Engineering Practice, 12:1179-1195, 2004.
209. G.M. Steil, B. Clark, S. Kanderian, and K. Rebrin, Modelling insulin action for development of close-loop artificial pancreas. Diabetes Technology & Therapeutics, 7(1):94-108, 2005.
210. R. Hovorka, F. Shojaee-Moradie, P.V. Carroll, L.J. Chassin, L.J. Cowrie, N.C. Jackson, R.S. Tudor, A.M. Umpleby, and R.H. Jones. Partitioning glucose distribution/transport, disposal and endogenous production during IVGTT. Am J Physiol Endocrinol Metab, 282:992-1007, 2002.
211. R. Hovorka, V. Canonico, L.J. Chassin, U. Haueter, M. Massi-Benedetti, M.O. Federica, T.R. Pieber, H.C. Schaller, L. Schaupp, T. Vering, and M.E. Wilinska. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiological Measurement, 25:905-920, 2004.
212. M. Giugliano, M. Bove, and M. Grattarola. Insulin release at the molecular level: Metabolic-electrophysiological modeling of the pancreatic beta-cells. IEEE Eng. Med. Biol. Mag., 47(5):611-623, May 2000.
213. K. Ogata. Modern, Control Engineering. Prentice-Hall International, Inc, Upper Saddle River, New Jersey, 3rd edition, 1997.
214. U. Fischer, W. Schenk, E. Salzsieder, G. Albrecht, P. Abel, and E.-J Freyse. Does physiological blood glucose control require an adaptive control strategy? IEEE Trans. Biomed. Eng., 34(8):575-582, Aug 1987.
215. C. Dalla Man, G. Toffolo, and C. Cobelli, Gluocse kinetics during meal:one vs two compartment minimal model. In Proceedings of the Second Joint EMBS/BMES Conference, pages 2222-2223, Houston, TX, USA, 23-26 October 2002. IEEE.
216. C. Dalla Man, R.A. Rizza, and C. Cobelli. Mixed meal simulation model of glucose-insulin system. In Proceedings of the 28th IEEE EMBS Annual International Conference, pages 307-310, New York City, USA, 30 August-3 September 2006. IEEE.
217. J.T. Sorensen, C.K. Colton, R.S. Hillman, and J.S. Soeldner. Use of a physiologic pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapies. Diabetes Care, 5(3):148-157, 1982.
218. M. Ader, G. Pacini, Y.J. Yang, and R. Bergman. Importance of glucose per se to intravenous glucose tolerance. Diabetes, 34:1093-1103, 1985.
219. F. J. Vega-Catalan, A. program, to estimate insulin sensitivity and pancreatic responsivity from an IVGTT using the minimal modeling technique. Computers and Biomedical Research, 23:1-9, 1990.
220. T. Van Herpe, B. Pluymers, M. Espinoza, G. Van den Berghe, and B. De Moor. A minimal model for glycemia control in critically ill patients, pages 5432-5435. IEEE, 30 August-3 September 2006.
221. R. Hovorka, L.J. Chassin, M.E. Wilinska, V. Canonico, J.A. Akwi, M.O. Federici, M. Massi-Benedetti, I. Hutzli, C. Zaugg, H. Kaufmann, M. Both, T. Vering, H.C. Schaller, L. Schaupp, M. Bodenlenz, and T.R. Pieber. Closing the loop: The adicol experience. Diabetes Technology & Therapeutics, 6(3):307-318, 2004.
222. J.T. Sorensen. A Physiological Model of Glucose Metabolism in Man and it Use to Design and Access Improved Insulin Therapies for Diabetes. PhD thesis, Dept.of Chemical Engineering, MIT, 1985.
223. S.M. Lynch and B.W. Bequette. Model predictive control of blood glucose in type i diabetes using subcutaneous glucose measurements. In Proceedings of the American Control Conference, Anchorage, AK, 8-10 May 2002.
224. T.L Yates and L.R. Fletcher. Prediction of a glucose appearance function from food using deconvolution. IMA Journal of Mathematics Applied in Medicine and Biology, 17:169-184, 2000.
225. Z. Trajanoski and P. Wach. Neural predictive controller for insulin delivery using the subcutaneous route. IEEE Trans. Biomed. Eng., 45(9):1122-1134, 1998.
226. N.L. Ricker. Model predictive control with state estimation. Ind. Eng. Chem. Res, 29:374-382, 1990.
227. M. E. Fisher and K. L. Teo. Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics. IEEE Trans. Biomed. Eng., 36(4):479-486, April 1989.
228. G.W. Swan. An optimal control model of diabetes mellitus. Bulletin of Mathematical Biology, 44(6):793-808, 1982.
229. M. Gopal. Modern Control System Theory. Wiley Eastern Ltd, New Delhi, 1984.
230. Anthony Zaknich. Principles of Adaptive Filters and Self-learning Systems. ISBN 1-85233-984-5. Springer-Verlag, 2005. Series on Advanced Textbooks in Control and Signal Processing.
231. B. Pagurek, J.S. Riordon, and S. Mahmoud. Adaptive control of the human glucose-regulatory system. Med. & Biol. Eng, 10:753-761, 1972.
232. M. Kikuchi, E. Machiyama, N. Kabei, and A. Yamada. Adaptive control system of blood glucose regulation, In Lindberg/Kaihara, editor, MEDINFO 80, pages 96-100. IFIP, North-Holland Publishing Company, 1980.
233. E. Sarti and P. Cruciani. Self-tuning control algorithm for wearable artificial pancreas. In Vol. 14. Proceedings of the Annual International Conference of the IEEE, volume 6, pages 2267-2269. Engineering in Medicine and Biology Society, 29 October-1 November 1992.
234. M. Morari and N.L. Ricker. Model Predictive Control Toolbox User's Guide. The Mathworks, Inc, Natick, MA, 1998.
235. C.E. García, D.M. Prett, and M. Morari, Model predictive control: Theory and practice- a survey. Automatica, 25(3):335-348, 1989.
236. R. Bellazzi, G. Nucci, and C. Cobelli. The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng. Med. Biol. Mag., 20(1):54-64, January-February 2001.
237. R.T. Stefani, B. Shahian, C.J. Savant, and G.H. Hostetter. Design of Feedback Control Systems. Oxford University Press, New York, 4th edition, 2002.
238. ∞ -norm bound and relations to risk sensitivity. System & Control Letters, 11:167-172, 1988.
239. ∞ control system design. In Proceedings of the 29th Conference on Decision and Control, Honolulu, Hawaii, December 1990.
240. ∞ control problems. IEEE Transactions on Automatic Control, 34(8):831-847, 1989.
241. H. Toivonen. Robust control method, AS-74.330 Postgraduate Course in Control Engineering, 2002. Process Control Laboratory, Abo Akademi [Online] Available at http://www.abo.fi/~htoivone/courses/AS74330.html.
242. ∞ theory. IEEE Trans. Biomed. Eng., 40(11):1133-1137, December 1993.
243. ∞ insulin injection control for blood glucose regulation in diabetic patients. IEEE Trans. Biomed. Eng., 52(10):1625-1631, October 2005.
244. A.V. Savkin and R.J. Evans. A new approach to robust control of hybrid systems over infinite time. IEEE Transactions on Automatic Control, 43(9):1292-1296, 1998.
245. A.V. Savkin and I.R. Petersen. Robust filtering and model validation for uncertain continuous-time systems with discrete and continuous measurements. International Journal of Control, 69(1):163-174, 1998.
246. A.V. Savkin and R.J. Evans. Hybrid Dynamical Systems. Controller and Sensor Switching Problems. Birkhäuser, Boston, Cambridge MA, 1st edition, 2002.
247. D.P. Bertsekas and I.B. Rhodes. Recursive state estimation for a set-membership description of uncertainty. IEEE transactions on automatic control, AC-16(2):117-128, April 1971.
248. D.A. Gough, S. Aisenberg, C.K. Colton, J.Girier, and J.S. Soeldner. The status of electrochemical sensors for in vivo glucose monitoring. Horm Metab Res Suppl, 7:10-22, 1977.
249. R.D. Beach, F. V. Kuster, and F. Moussy. Subminiature implantable potentiostat and modified commercial telemetry device for remote glucose monitoring. IEEE Transaction in Instrumentation and Measurement, 48(6): 1239-1245, 1999.
250. K.C. McIvor, J.L. Cabernoch, N.M. Van Antwerp, E.C. Halili, and J.J. Mastrototaro. Glucose sensor package system, 2002. US Patent 6,360,888 B1.
251. S.J. Updike, M.C. Shults, B.J. Gilligan, and R.K. Rhodes. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care, 23(2):208-214, 2000.
252. T. Yipintsoi, L.C Gatewood, E. Ackerman, P.L. Spivak, G.D. Molnar, J.W. Rosevear, and F.J. Service. Mathematical analysis of blood glucose and plasma insulin responses to insulin infusion in healthy and diabetic subjects. Computers in biology & medicine, 3:71-78, 1973.